351 related articles for article (PubMed ID: 25384772)
1. Black Molds and Melanized Yeasts Pathogenic to Humans.
Chowdhary A; Perfect J; de Hoog GS
Cold Spring Harb Perspect Med; 2014 Nov; 5(8):a019570. PubMed ID: 25384772
[TBL] [Abstract][Full Text] [Related]
2. Dematiaceous fungi.
Revankar SG
Mycoses; 2007 Mar; 50(2):91-101. PubMed ID: 17305771
[TBL] [Abstract][Full Text] [Related]
3. Melanized fungi in human disease.
Revankar SG; Sutton DA
Clin Microbiol Rev; 2010 Oct; 23(4):884-928. PubMed ID: 20930077
[TBL] [Abstract][Full Text] [Related]
4. Cutaneous infections due to opportunistic molds: uncommon presentations.
Vennewald I; Wollina U
Clin Dermatol; 2005; 23(6):565-71. PubMed ID: 16325064
[TBL] [Abstract][Full Text] [Related]
5. Indoor wet cells as a habitat for melanized fungi, opportunistic pathogens on humans and other vertebrates.
Wang X; Cai W; van den Ende AHGG; Zhang J; Xie T; Xi L; Li X; Sun J; de Hoog S
Sci Rep; 2018 May; 8(1):7685. PubMed ID: 29769615
[TBL] [Abstract][Full Text] [Related]
6. Epidemiology, clinical manifestations, and therapy of infections caused by dematiaceous fungi.
Brandt ME; Warnock DW
J Chemother; 2003 Nov; 15 Suppl 2():36-47. PubMed ID: 14708965
[TBL] [Abstract][Full Text] [Related]
7. North American dimorphic fungal infections in children.
Montenegro BL; Arnold JC
Pediatr Rev; 2010 Jun; 31(6):e40-8. PubMed ID: 20516233
[No Abstract] [Full Text] [Related]
8. Emerging fungal pathogens.
Anaissie EJ; Bodey GP; Rinaldi MG
Eur J Clin Microbiol Infect Dis; 1989 Apr; 8(4):323-30. PubMed ID: 2497012
[TBL] [Abstract][Full Text] [Related]
9. Characteristics of pathogenic fungi and antifungal therapy in cystic fibrosis.
Müller FM; Seidler M
Expert Rev Anti Infect Ther; 2010 Aug; 8(8):957-64. PubMed ID: 20695750
[TBL] [Abstract][Full Text] [Related]
10. Identification and antifungal susceptibility of fungi isolated from dermatomycoses.
Silva LB; de Oliveira DB; da Silva BV; de Souza RA; da Silva PR; Ferreira-Paim K; Andrade-Silva LE; Silva-Vergara ML; Andrade AA
J Eur Acad Dermatol Venereol; 2014 May; 28(5):633-40. PubMed ID: 23556501
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic approaches to subcutaneous mycoses.
Koga T; Matsuda T; Matsumoto T; Furue M
Am J Clin Dermatol; 2003; 4(8):537-43. PubMed ID: 12862496
[TBL] [Abstract][Full Text] [Related]
12. Therapy of infections caused by dematiaceous fungi.
Revankar SG
Expert Rev Anti Infect Ther; 2005 Aug; 3(4):601-12. PubMed ID: 16107199
[TBL] [Abstract][Full Text] [Related]
13. Opportunistic filamentous mycoses: aspergillosis, mucormycosis, phaeohyphomycosis and hyalohyphomycosis.
Perusquía-Ortiz AM; Vázquez-González D; Bonifaz A
J Dtsch Dermatol Ges; 2012 Sep; 10(9):611-21; quiz 621-2. PubMed ID: 22925358
[TBL] [Abstract][Full Text] [Related]
14. Alternaria infections: laboratory diagnosis and relevant clinical features.
Pastor FJ; Guarro J
Clin Microbiol Infect; 2008 Aug; 14(8):734-46. PubMed ID: 18727797
[TBL] [Abstract][Full Text] [Related]
15. Subcutaneous mycoses in coastal Karnataka in south India.
Bhat RM; Monteiro RC; Bala N; Dandakeri S; Martis J; Kamath GH; Kambil SM; Asha Vadakayil R
Int J Dermatol; 2016 Jan; 55(1):70-8. PubMed ID: 26267755
[TBL] [Abstract][Full Text] [Related]
16. Fungal Musculoskeletal Infections.
Henry MW; Miller AO; Walsh TJ; Brause BD
Infect Dis Clin North Am; 2017 Jun; 31(2):353-368. PubMed ID: 28483045
[TBL] [Abstract][Full Text] [Related]
17. Evaluation and management of fungal infections in immunocompromised patients.
Venkatesan P; Perfect JR; Myers SA
Dermatol Ther; 2005; 18(1):44-57. PubMed ID: 15842612
[TBL] [Abstract][Full Text] [Related]
18. Emerging subcutaneous mycoses by opportunistic filamentous fungi: A retrospective study in Northwest Spain.
Taibo A; Seoane Estévez A; Martínez Campayo N; Rodríguez Mayo M; Arévalo Bermúdez MDP; Fonseca E
Mycoses; 2023 Oct; 66(10):891-897. PubMed ID: 37381098
[TBL] [Abstract][Full Text] [Related]
19. Terbinafine: broad new spectrum of indications in several subcutaneous and systemic and parasitic diseases.
Pérez A
Mycoses; 1999; 42 Suppl 2():111-4. PubMed ID: 10865916
[TBL] [Abstract][Full Text] [Related]
20. Black fungi: clinical and pathogenic approaches.
De Hoog GS; Queiroz-Telles F; Haase G; Fernandez-Zeppenfeldt G; Attili Angelis D; Gerrits Van Den Ende AH; Matos T; Peltroche-Llacsahuanga H; Pizzirani-Kleiner AA; Rainer J; Richard-Yegres N; Vicente V; Yegres F
Med Mycol; 2000; 38 Suppl 1():243-50. PubMed ID: 11204152
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
